JAMA | The Latest Medical Research, Reviews, and Guidelines Follow Managing Adverse Effects of Incretin-Based Medications for Obesity This JAMA Insights explores optimal strategies for managing the adverse effects associated with incretin-based medications for obesity, including semaglutide and tirzepatide. https://jamanetwork.com/journals/jama/fullarticle/2836876 jamanetwork.com
